|
|
||||||||
J Biol Chem, Vol. 275, Issue 5, 3093-3099, February 4, 2000
From the Departments of Collagen XVII is a hemidesmosomal transmembrane
molecule important for epithelial adhesion in the skin. It exists in
two forms, as a full-length protein and as a soluble ectodomain that is
shed from the keratinocyte surface by furin-mediated proteolysis. To obtain information on the conformation and the functions of this unusual collagen, its largest collagenous domain, Col15, was expressed in a eukaryotic episomal expression system and purified by DEAE and
fast protein liquid- Mono S chromatography. The protein was triple-helical (Tm of 26.5 °C) when produced
in cultures containing ascorbic acid. When the vitamin supply was
limited, the 4-hydroxyproline content was reduced from 74 to 9%,
which, in turn, resulted in a drastic reduction of the stability of the
triple helix. The glycine substitution mutation G627V associated with
junctional epidermolysis bullosa, a human blistering skin disease, also
had a striking effect on thermal stability of rCol15 causing partial unfolding already at 4 °C. Col15 promoted cell adhesion of
epithelial and fibroblastic cell lines with a Collagens are a family of closely related, although genetically
distinct, extracellular matrix proteins. Each collagen consists of
three polypeptide chains, Based on its localization at the basolateral surface of basal
keratinocytes, collagen XVII is likely to link the cytoskeleton to the
extracellular matrix. Indeed, its intracellular domain interacts with
the Low abundance of collagen XVII in tissues has impeded purification of
sufficient amounts of native collagen for functional studies.
Therefore, we produced the largest collagenous domain, Col15, as a
eukaryotic recombinant fragment. Under physiological conditions, it
contains adequate amounts of 4-hydroxyproline and forms a stable triple
helix which, however, is destabilized by lack of 4-hydroxyproline or by
substitution of a particular glycine residue. Further, we demonstrate
that the recombinant domain can promote cell adhesion and is the target
of autoantibodies in patients with blistering autoimmune diseases.
Production of a Bacterial Fusion Protein and Domain-specific
Antibodies--
For production of domain-specific antibodies against
collagen XVII, a bacterial fusion protein,
GST1-Col15-2 (see Fig.
1A), spanning amino acids 774-807 (5, 17), was generated
using the GST Gene Fusion System (Amersham Pharmacia Biotech, Uppsala,
Sweden). The corresponding human cDNA (GenBank accession number
M911669) was amplified from keratinocyte mRNA by reverse
transcriptase PCR (Titan reverse transcriptase PCR, Roche Molecular
Biochemicals, Mannheim, Germany) with the sense primer
5'-GCGCGGATCCGACCCAGGAAAGCCAGGT -3' (nucleotides
2425-2442) and the antisense primer
5'-GCGCGGAATTCACTTGCCTGGAGCTCC Construction and Transfection of Wild-type and Mutated Eukaryotic
Expression Vectors--
A cDNA fragment corresponding to the Col15
domain of human collagen XVII cDNA was amplified by Titan reverse
transcriptase PCR of keratinocyte mRNA according to the
manufacturer's instructions. The sense primer was
5'-GCGCGCTAGCAGGAAGCCCTGGCCCTAAA-3' (nucleotides 1804-1821) and the antisense primer
5'-ATTAGCGGCCGCTCACTTGCCTGGAGCTCC-3' (nucleotides
2512-2526), the underlined sequences representing the NheI
and NotI restriction sites, respectively. After
NheI and NotI digestions, the fragment was cloned
into a modified episomal expression vector pCEP-Pu containing the
signal peptide sequence of BM-40 and a puromycin resistance gene (29).
The correct sequence of the clone pCEP-Col15 was verified by
dideoxynucleotide sequencing. It corresponded to amino acids 567-807
of collagen XVII.
The COL17A1 mutation G627V, resulting from a G to T
transversion in nucleotide position 1985 (16), was introduced into
pCEP-Col15 clone using a QuikChange site-directed mutagenesis kit
(Stratagene Europe, Amsterdam, The Netherlands) and the following sense
and antisense primers (nucleotides 1967-2000, mutated bases
underlined): 5'-GCCAGAGAGGGCGAGAAGTCCCCATGGGACCTCG-3' and
5'-CGAGGTCCCATGGGGACTTCTCGCCCTCTCTGGC-3' (see Fig.
1A). The generation of the desired point mutation in the
clone pCEP-Col15-G627V was verified by dideoxynucleotide sequencing.
Human kidney 293-EBNA cells constitutively expressing the EBNA-1
protein of Epstein-Barr virus to enhance transfection efficiency were
used according to the manufacturer's instructions (Invitrogen, Groningen, The Netherlands). The cells were grown in Dulbecco's modified Eagle's medium and nutrient mix F-12 medium (Life
Technologies, Inc.) containing 10% fetal calf serum and 0.35 mg/ml
G418 (Invitrogen). One million cells/10-cm culture dish were
transfected with 25 µg of pCEP-Col15 or pCEP-Col15-G627V DNA using
the calcium phosphate method. Following a selection with 0.5 µg/ml
puromycin (Sigma, Deisenhofen, Germany), the transfected cells were
grown to confluence, washed twice with phosphate-buffered saline, and
switched to serum-free medium containing 50 µg/ml ascorbic acid
(Fluka, Deisenhofen, Germany). Freshly made ascorbic acid was added
every 24 h or, in some experiments, only every 48 h, or
omitted totally. The media were collected every 48 h, cooled,
centrifuged to remove cellular debris, and supplemented with 1 mM Pefablock (Merck, Darmstadt, Germany) and 1 mM N-ethylmaleimide (Sigma).
Purification and Amino Acid Analysis of Recombinant Col15
Domain--
Medium containing the recombinant Col15 domain, called
rCol15 hereafter, was dialyzed against 0.05 M Tris-HCl, pH
8.6, at 4 °C and chromatographed on a DEAE-cellulose column
(Whatman, Maidstone, U. K.) equilibrated in the same buffer. rCol15
did not bind to DEAE-cellulose, but a significant amount of
contaminating proteins was removed with this step. For further
purification, rCol15 fractions were dialyzed against 0.02 M
citrate, pH 5, at room temperature and passed onto an FPLC Mono S
column (Amersham Pharmacia Biotech) equilibrated in the same buffer and
subsequently eluted with a linear 0-0.5 M NaCl gradient.
For amino acid analysis, Mono S-purified rCol15 was blotted to
polyvinylidene difluoride membrane (Problott, Perkin-Elmer Applied
Biosystems) and hydrolyzed under vapor-phase condition using 6 N HCl for 75 min at 150 °C in a nitrogen atmosphere. The amino acid composition was analyzed with the 421-amino acid analyzer (Perkin-Elmer) according to the manufacturer's instructions, with a
slight modification for optimal collagen sample analysis.
Proteolytic Digestions of rCol15 Domain--
Digestion of
DEAE-purified rCol15 with highly purified bacterial collagenase
(Advanced Biofactures Inc., Lynbrook, NY) was performed with 40 units/ml enzyme in 0.05 M Tris-HCl, 0.01 M
CaCl2, pH 7.7, at 37 °C for 2 h. For testing the
triple-helical conformation with trypsin as a probe (30), 10 µg/ml
DEAE-purified rCol15 or rCol15-G627V was treated with 10 µg/ml
trypsin (Boehringer Ingelheim) at increasing temperatures between 4 and
40 °C for 2 min, and the reactions were stopped by adding 10 µg/ml
soybean trypsin inhibitor (Sigma). For immunoblotting with Ab-Col15-2 using standard techniques, SDS-polyacrylamide gel electrophoresis with
6-22% polyacrylamide gradient gels was used. The scanning of the
immunoblot signals and quantitation of digestion products were
performed with Image Master VDS for gel electrophoresis and Image
Master software (Amersham Pharmacia Biotech).
Circular Dichroism Analysis of rCol15 Domain--
Purified
rCol15 was dissolved in 0.02 mM sodium phosphate, 0.05 M NaCl, pH 7.4, at 0.15 mg/ml. Circular dichroism spectra at 4 °C and 50 °C were recorded in a DC6 Jobin Yvon
spectropolarimeter equipped with a quartz cell (0.1-mm path length)
thermostatted with a water jacket. Melting curves were measured by
monitoring ellipticities at 221 nm as a function of temperature in the
water jacket of the CD cell. The temperature was raised linearly at a
rate of 12 °C/h in a programmable water bath. The degree of helicity, F(T), of the peptide was calculated
according to
Cell Adhesion Assays--
Skin epithelial cells (A431, HaCaT)
and lung fibroblasts (L132, Wi26) were grown as described (6, 31).
Multiwell tissue culture plates (96 wells, Costar Corp., Faust,
Germany) were coated with serial dilutions of collagen IV (5 µg/ml,
kindly provided by Dr. Klaus Kühn, Max Planck Institute for
Biochemistry, Martinsried, Germany) or of DEAE-purified rCol15 (100 µg/ml) overnight at 4 °C. For some experiments, rCol15 was
denatured at 56 °C for 20 min before coating. After saturation with
1% bovine serum albumin (fraction V, Sigma), the plates were used
immediately for short term (30, 45, and 60 min) adhesion assays (31).
For cell adhesion inhibition assays, the monoclonal antibody P4C10 to
human Detection and Immunoadsorption of Circulating
Autoantibodies with rCol15--
For testing IgG and IgA reactivity
with rCol15, bullous pemphigoid and linear IgA disease patient sera
were used, respectively. The diagnoses were based on clinical findings,
characteristic histology, and demonstration of linear autoantibody
binding at the skin basement membrane zone with immunofluorescence
techniques (32). For immunoblotting with rCol15 as antigen, the sera
(diluted 1:20) were incubated overnight, and alkaline
phosphatase-labeled chain-specific anti-human IgG and IgA (Sigma)
second antibodies were incubated for 1.5 h.
For affinity adsorption of patient autoantibodies, a nitrocellulose
strip containing rCol15 was prepared as described (33). 50 µl of
serum diluted 1:10 in blotting buffer was reacted with the strip
overnight, and the antibodies were eluted in 200 µl of 0.1 M glycine HCl buffer, pH 2.5. After neutralization, the immunoglobulins were used for immunofluorescence staining of intact or
sodium chloride split (34) human skin with fluorescein
isothiocyanate-labeled anti-human IgG or IgA (Dako) second antibodies.
Controls included sera from healthy volunteers or persons with
unrelated skin diseases.
Expression and Purification of the rCol15 Domain of Collagen
XVII--
The Col15 domain of collagen XVII consists of 242 amino
acids (residues 567-808 of collagen XVII) and is thus remarkably
larger than any of the 14 other collagenous domains, which vary from 14 to 45 amino acids in length (Fig.
1A). Its calculated molecular mass deduced from the cDNA sequence is 2245 kDa, and its predicted amino acid sequence is characterized by 80 perfect Gly-Xaa-Yaa triplets
with one Gly-Xaa-Gly (Gly-Ser-Gly) interruption in positions 639-641.
A cDNA fragment of 723 base pairs corresponding to Col15 was
generated with reverse transcriptase PCR from human keratinocyte mRNA and cloned into a modified episomal expression vector pCEP-Pu (29). The resulting clone, pCEP-Col15, was transfected into human
embryonic kidney 293-EBNA cells. Compared with nontransfected controls,
the transfected cells secreted approximately 10 µg/ml of an
additional polypeptide with an apparent molecular mass of 34 kDa (Fig.
1B). This recombinant fragment, designated rCol15, was
identified in immunoblots with the antibody Ab-Col15-2 (Fig. 1C) against a carboxyl-terminal segment of the Col15 domain.
In a first purification step by DEAE-cellulose chromatography, rCol15 did not bind but was partially purified by elimination of other medium
proteins (Fig. 1B). Further purification was achieved using FPLC Mono S chromatography and elution with a linear NaCl gradient (Fig. 1B). rCol15 was sensitive to highly purified bacterial
collagenase (Fig. 1D), confirming its collagenous nature.
4-Hydroxyproline Content of rCol15 Domain--
To determine the
extent of prolyl hydroxylation and to analyze the effect of 4-Hyp
content on triple helix stability, rCol15 was purified and subjected to
amino acid analysis. When produced in the presence of 50 µg/ml
ascorbic acid (added to the media every 24 h), rCol15 contained 20 4-Hyp residues/polypeptide chain. The maximum number of Pro residues in
the Yaa position of the Gly-Xaa-Yaa triplets which serve as substrate
for prolyl-4-hydroxylase (35) is 27. Thus, 74% of the eligible prolyl
residues were hydroxylated. Because the total number of proline
residues in rCol15 is 53, the 4-Hyp:Pro + 4-Hyp ratio was 37.7%. When
ascorbic acid was added only every 48 h, the number of 4-Hyp
residues/polypeptide chain was only 2.5.
Conformation and Thermal Stability of rCol15 Domain--
The
triple-helical conformation and the thermal stability of rCol15 were
assessed by CD spectra. At 4 °C, purified fully hydroxylated rCol15
produced a spectrum characteristic for triple-helical collagens (Fig.
2A). The extreme values of
mean residue ellipticity (4,700 at 221 nm and
Limited trypsin digestion (30) was also used to probe the
triple-helical structure of rCol15. The digestions were performed by
reacting 10 µg/ml rCol15 with 10 µg/ml trypsin for 2 min at increasing temperatures between 4 and 40 °C. With this assay, fully
hydroxylated rCol15 lost its stability to about 50% at 25 °C (Fig.
3A) and rCol15 produced
without ascorbic acid at a significantly lower temperature of 18 °C
(Fig. 3B).
Mutated Col15 Domain Is Inadequately Folded--
Site-directed
mutagenesis was used to generate a Gly to Val substitution at amino
acid residue 627 within the amino-terminal third of the Col15 domain.
This gene defect has been reported in a patient with junctional
epidermolysis bullosa who was compound heterozygous for a nonsense
mutation on the other allele and, therefore, functionally homozygous
(hemizygous) for the glycine substitution (16). The clone containing
the mutation pCEP-Col15-G627V was expressed in 293-EBNA cells, and the
corresponding recombinant fragment, rCol15-G627V, was partially
purified with DEAE-cellulose chromatography. Thermal stability of
rCol15-G627V was probed by trypsin digestion at increasing temperatures
between 4 and 30 °C. The 34-kDa rCol15-G627V fragment was partially
degraded into an intermediate digestion product of about 26 kDa already
at 4 °C, and the 34-kDa band disappeared entirely at 16 °C,
indicating complete unfolding (Fig. 3C). The intermediate
26-kDa product resisted trypsin between 4 and 16 °C but gradually
lost this resistance between 18 and 26 °C; its melting temperature
was about 21 °C (Fig. 3C). These experiments demonstrated
that the glycine substitution significantly reduced the conformational
stability of the Col15 domain.
The major 26-kDa intermediate product was detectable with the antibody
Ab-Col15-2, which recognizes the 34 most COOH-terminal amino acids of
Col15 (Fig. 1A), indicating that this product contained the
COOH terminus of Col15 domain. Therefore, it is likely that the stretch
of 60 amino acids located amino-terminally from the G627V substitution
was not folded correctly and thus sensitive to trypsin digestion. The
formation of an intermediate digestion product of 26 kDa with a melting
temperature only slightly lower than that of nonmutated rCol15 suggests
that the region of Col15 located carboxyl-terminally of the mutation
was folded correctly.
Col15 Domain Promotes Adhesion of Epithelial Cells and
Fibroblasts--
To obtain more information on the structure-function
relationships of collagen XVII, rCol15 was tested for its ability to induce adhesion of HaCaT, A431, L132, and Wi26 cells. rCol15 induced cell adhesion in a concentration-dependent manner (Fig.
4A). Interestingly, the cell
adhesion-promoting activity of denatured rCol15 was higher than of
native rCol15. In both cases, the maximal adhesion plateaus were lower
than those observed with collagen IV, which was used as a positive
control (Fig. 4B). Maximum cell adhesion to rCol15 was
obtained at 50-100 µg/ml, the corresponding value for collagen IV
being 2-5 µg/ml. Spreading of L132 fibroblasts and of Wi26 epithelial cells was induced by rCol15, but to a lesser extent than by
collagen IV (Fig. 4C). HaCaT cells (Fig. 4C) do
not usually display a distinct spread morphology, and there was no
major difference between these cells adhering to rCol15 or collagen IV.
However, on native rCol15, HaCaT cells formed an alignment like
"necklace of pearls" (Fig. 4C). Cell adhesion inhibition
experiments with function-blocking anti-integrin antibodies indicated
that integrins of the Col15 Domain Is Targeted by Autoantibodies in Bullous
Diseases--
To investigate whether Col15 contained epitopes relevant
for human autoimmune diseases, rCol15 was used as antigen in
immunoblots with sera from patients with bullous pemphigoid or linear
IgA disease. In both diseases, circulating and tissue-bound
autoantibodies to collagen XVII have been reported (23-28). Sixty-six
patient sera that contained IgG or IgA reactive with collagen XVII and its soluble ectodomain (32) were assessed for reactivity with rCol15.
Of these, 23 (35%) contained either IgG or IgA recognizing rCol15
(Fig. 6A). As controls, 60 normal human sera or sera of patients with unrelated skin diseases were
used. None of these showed IgG or IgA reactivity with rCol15. To
evaluate the pathophysiological relevance of the autoantibodies
reactive with rCol15 on immunoblots, IgG from pemphigoid sera was
affinity-purified with rCol15 bound to nitrocellulose. After elution
from the nitrocellulose matrix, the immunoglobulins were used for
indirect immunofluorescence staining of normal human skin. IgG from
bullous pemphigoid sera stained the basement membrane zone of normal
human skin (Fig. 6B), indicating that the circulating
autoantibodies that recognized rCol15 in immunoblots reacted with
native collagen XVII in situ.
The primary structure of collagen XVII deduced from the cDNA
sequence suggests that its extracellular domain may form a collagen triple helix with multiple interruptions. Because the authentic protein
is not available in amounts allowing conformational analysis by CD
spectroscopy, the largest collagenous domain, Col15, was produced as a
eukaryotic recombinant fragment that was fully triple-helical. Of
pivotal importance for this tertiary structure was an adequate supply
of ascorbic acid in the cell culture media. This vitamin is an
essential cofactor for the hydroxylation of prolyl residues to 4-Hyp,
which in turn is needed for stabilization of the collagen triple helix
(35). This is an important aspect because in previous studies
addressing the molecular shape and conformation of collagen XVII, a
protein produced without ascorbic acid was analyzed (7, 8, 37).
The midpoint of the helix-to-coil transition,
Tm, of 26.5 °C for the rCol15 was relatively
low. This was not the result of underhydroxylation because the 4-Hyp
content of rCol15 was 83/1000 amino acid residues, which agrees well
with that of other collagens (54-126/1000 residues; Ref. 34). The
reduced thermal stability thus is a consequence either of the shorter
length of rCol15 or of its amino acid sequence that allows the
formation of a less stable triple helix (38, 39). In the full-length
protein, the triple helix of Col15 is more stable because it is
presumably stabilized by cooperative interactions with neighboring
triple-helical domains (6).
Unlike many other glycine substitution mutations in the genes for skin
basement membrane collagens (20, 21, 40), the mutation G627V causes a
drastic reduction of the conformational stability of the Col15 domain.
The mutated fragment was partially digested by trypsin already at
4 °C and completely abolished at 16 °C. A carboxyl-terminal
intermediate digestion product had a Tm of about
21°C. These findings suggest that the G627V substitution changes the
folding and decreases the thermal stability of collagen XVII. In
concert with this, G627V has been shown to be associated with
junctional epidermolysis bullosa in a patient who was functionally homozygous for the glycine substitution (16). In the skin of the
proband, the extracellular domain of collagen XVII was absent, whereas
some intracellular collagen XVII epitopes were discerned with
immunofluorescence staining. This staining pattern, together with our
finding that mutated rCol15-G627V was easily degraded in
vitro, suggests that the mutated ectodomain of collagen XVII in
the skin of the proband was not folded correctly and was consequently sensitive to degradation. Thus, the absence of functional Col15 domain
in the junctional epidermolysis bullosa patient's skin led to
deficient epidermal adhesion and to the phenotype of skin fragility.
In concert with the genetic evidence for the role of collagen XVII in
dermal-epidermal integrity, rCol15 promoted cell adhesion in
vitro in a The functional significance of Col15 for epidermal adhesion is
underscored further by the fact that in acquired blistering skin
disorders autoantibodies target this domain. Using rCol15 as antigen,
we showed that approximately one-third of the tested autoimmune sera
contained either IgG or IgA reactive with it. This is in contrast to
previous studies with mainly bacterial recombinant fragments, which
found most immunodominant epitopes in the NC16a domain (25, 49, 50),
some in the distal amino- and carboxyl-terminal regions of the
molecule, but none in the Col15 domain (23, 28, 51). By affinity
adsorbing the rCol15-reactive immunoglobulins from the patient sera, we
also showed that the circulating autoantibodies against rCol15 target
collagen XVII at the epidermal basement membrane zone in
situ. This suggests that tissue-bound autoantibodies to collagen
XVII perturb Col15 functions by interfering with its cell adhesion
activity and thereby contribute to blister formation.
In conclusion, recombinant expression of human transmembrane collagen
XVII in eukaryotic cells opens new possibilities for assessing the
structure-function relationships of this unusual collagen. Furthermore,
the recombinant expression system should be useful in elucidating the
effects of human mutations or autoantibody binding on the stability and
ligand binding of collagen XVII.
We thank Drs. Eddie Kohfeldt, Ulrike Mayer,
and Rupert Timpl (Max Planck Institute for Biochemistry, Martinsried,
Germany) for the pCEP-Pu expression vector and for help and advice
concerning the 293-EBNA expression system; Dr. Klaus Kühn for
collagen IV and Dr. Norbert Fusenig for the HaCaT cells. We also
acknowledge the excellent technical assistance of Margit Schubert,
Michaela Floeth, Monika Pesch, and Anja Mattila and the expert help of Mika Kihlström with the illustrations.
*
This work was supported in part by grants from the Academy
of Finland, the Alexander von Humboldt Foundation, and the Oulu University Hospital (to K. T.), by Grants Br 1475/1-2 and SFB 293/B3
(to L. B.-T.) and Br 1497/1-2 (to P. B.) from the Deutsche Forschungsgemeinschaft as well as by EU Contract BM4CT-97-2062.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
**
Researcher of the CNRS and supported by the University of Cologne,
Germany, and by grants Kr 558/10-2 and Au 86/5-1 from the Deutsche Forschungsgemeinschaft.
§§
To whom correspondence should be addressed: Dept. of Dermatology,
University of Münster, Von-Esmarch Strasse 56, 48149 Münster, FRG. Tel.: 49 251 83 56535; Fax: 49 251 83 56534;
E-mail: tuderma@uni-muenster.de.
The abbreviations used are:
GST, glutathione
S-transferase;
PCR, polymerase chain reaction;
rCol15, recombinant Col15 domain of collagen XVII;
FPLC, fast protein liquid
chromatography;
4-Hyp, 4-hydroxyproline.
Collagen XVII Is Destabilized by a Glycine Substitution Mutation
in the Cell Adhesion Domain Col15*
§,
**,
,
,
,
§§
Dermatology and
¶ Physiological Chemistry, University of Münster, 48149 Münster, Germany, the Departments of § Dermatology and

Medical Biochemistry, University of Oulu,
90220 Oulu, Finland, and the
Department of Biochemistry,
University of Cologne, 50931 Cologne, Germany
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
1 integrin-mediated
mechanism. In concert with this, in acquired autoimmune blistering skin
diseases, circulating IgG and IgA autoantibodies were found to target rCol15r.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
chains, which contain a characteristic repeating "collagenous" triplet amino acid sequence -Gly-Xaa-Yaa-, where Xaa and Yaa denote amino acids other than glycine. In all collagen types, the
chains also have non-collagenous domains of
varying sizes (1). Typically, the three polypeptide chains are twisted
around each other into a collagen triple helix; however, only
suggestive data for this exist in the recently characterized transmembrane collagens, types XIII and XVII (for review, see Ref. 2).
Collagen XVII, also known as the 180-kDa bullous pemphigoid antigen, or
BP180, is a structural component of hemidesmosomes, multiprotein
complexes that mediate the adhesion of epidermal keratinocytes to the
underlying basement membrane (3, 4). The cDNA sequence codes for a
type II integral transmembrane protein of 1497 amino acids, with an
intracellular domain of 560 amino acids, a short transmembrane stretch,
and an extracellular collagenous domain of 914 amino acids with
multiple interruptions. The length of the individual collagenous
subdomains varies from 14 to 242 amino acid residues (5). Recently, it
was established that collagen XVII exists as two molecular forms,
i.e. as a full-length transmembrane homotrimer of three
180-kDa
1(XVII) chains and as a 120-kDa soluble form that
corresponds to the extracellular domain and is presumably released from
the cell surface through furin-mediated proteolytic processing (6, 7).
In some situations also a shorter, approximately 90-100-kDa fragment,
has been observed (3, 4, 6). Very little is known about the molecular
shape of collagen XVII under physiological conditions. Rotary shadowing electron microscopy of collagen XVII from bovine cells lines or of
recombinant fragments expressed in COS-1 cells revealed asymmetric molecules with an elongated shape (8, 9). A 90-kDa pepsin/trypsin fragment of collagen XVII in detergent extracts of keratinocytes was
resistant to further trypsin digestion at physiological temperatures, suggesting that it was triple-helical (6).
4 integrin subunit and is essential for its incorporation into
hemidesmosomes (10-13). The
6 integrin subunit interacts with the
extracellular NC16a domain adjacent to the transmembrane stretch (14).
The role of collagen XVII in maintaining adhesion is supported by
studies on pathological skin conditions. Mutations in the collagen XVII
gene, COL17A1, lead to junctional epidermolysis bullosa, a
hereditary blistering skin disease with epidermal detachment from the
basement membrane (15-21). Tissue-bound and circulating IgG and IgA
autoantibodies to collagen XVII are also associated with skin
blistering in autoimmune bullous skin diseases (22-28). Nevertheless,
the conformation, the functions, and most ligands of the collagenous
ectodomain have remained elusive.
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
3 (nucleotides 2512-2526). Following digestions with BamHI and
EcoRI (restriction sites underlined) the fragment was cloned
into the 3'-end of the GST gene in the expression vector pGEX-2T
(Amersham Pharmacia Biotech), and dideoxynucleotide sequence analysis
was performed. The construct was expressed in Escherichia
coli DH5
, and the fusion protein was purified using the
GST-glutathione affinity system (Amersham Pharmacia Biotech). For
production of the antibody Ab-Col15-2, rabbits were immunized using
standard conditions (Eurogentec, Ougrée, Belgium).
where
(Eq. 1)
T is the ellipticity value
measured at temperature T.
n, the
ellipticity value of the triple-helical polypeptide, does not depend on
T and was measured at T = 4 °C.
d,T is the ellipticity value for the
denatured polypeptide and was linearly dependent on T.
d,T at temperatures below the melting
temperature Tm was determined by linear
extrapolation from
T values above
Tm.
1 integrin (Life Technologies; diluted 1:500 and 1:2000) was
added to the cells before plating. Adherent cells were photographed
using an Axiovert phase contrast microscope (Zeiss, Oberkochen,
Germany). All assays were done as triplicates.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

View larger version (33K):
[in a new window]
Fig. 1.
Collagen XVII and the Col15 domain.
Panel A, schematic representation of collagen XVII, its shed
ectodomain, and the Col15 domain. Collagen XVII is a type II
transmembrane protein of 1497 amino acids with an amino-terminal
intracellular domain of 466 amino acids, a transmembrane domain of 23 amino acids, and a carboxyl-terminal extracellular domain of 1008 amino
acids in length. The ectodomain contains 15 collagenous domains varying
from 14 to 242 amino acids (white bars) and 16 non-collagenous domains (black bars). The white
oval indicates the transmembrane domain (TM). The
recombinant fragment rCol15 (light gray bar) corresponds to
the largest collagenous domain, Col15. WT indicates the
wild-type collagen XVII nucleotide sequences (nucleotides 1978-1989)
and M the nucleotide sequences the mutated recombinant
fragment rCol15-G627V containing a G to T transversion at nucleotide
position 1985 (underlined). The positions of the bacterial
fusion protein GST-Col15-2 and the corresponding antibody Ab-Col15-2
recognizing the COOH terminus of the Col15 domain are indicated by the
small black bars. Panels B-D, purification of
the recombinant Col15 domain, rCol15. Panel B, medium from
293-EBNA cells transfected with an episomal expression vector coding
for the Col15 domain of collagen XVII was precipitated, run on a
reducing SDS-polyacrylamide gel electrophoresis, and stained with
Coomassie Blue. Compared with nontransfected cells (not shown), an
additional protein of about 34 kDa was detected (lane 1) and
named rCol15. It was purified further by DEAE-chromatography
(lane 2) and Mono S FPLC (lane 3). Panel
C, in immunoblot, the antibody Ab-Col15-2 detected both the
180-kDa full-length
1(XVII) chain in human keratinocyte extracts
(lane 1) and the 34-kDa rCol15 (lane 2). The
immunopositive band of an apparent molecular mass of about 70 kDa in
lane 2 was present in small amounts in some but not all
preparations; it is likely to represent a dimer of rCol15. Panel
D, collagenase digestion of DEAE-purified rCol15. rCol15 was
incubated for 2 h at 37 °C without (lane 1) and with (lane 2) highly purified
bacterial collagenase, run on a reducing SDS-polyacrylamide gel
electrophoresis, and stained with Coomassie Blue.
52,500 deg × cm2 × dmol
1 at 197 nm) were comparable to
those produced by triple-helical collagen I (36). At 50 °C, rCol15
had a CD spectrum of randomly coiled polypeptides (Fig. 2A).
The thermal stability was monitored by measuring the signal at 221 nm
as a function of temperature. The transition curve of rCol15 revealed a
melting temperature of 26.5 °C (Fig. 2B).

View larger version (15K):
[in a new window]
Fig. 2.
Circular dichroism spectroscopy of
rCol15. Panel A, rCol15 was dissolved in 0.02 mM sodium phosphate, 0.05 M NaCl, pH 7.4, at
0.15 mg/ml, and CD spectra were recorded in a 0.1-mm cuvette
equilibrated at 4 °C or 50 °C. Panel B, melting curves
were determined by constant monitoring of the CD at 221 nm, and the
degree of helicity F was calculated as described under
"Materials and Methods." The temperature was raised at
12 °C/h.

View larger version (83K):
[in a new window]
Fig. 3.
Trypsin digestions of rCol15.
DEAE-purified rCol15 was treated with 10 µg/ml trypsin for 2 min at
increasing temperatures between 4 and 40 °C, and the reactions were
stopped by adding soybean trypsin inhibitor. Scanning and quantitation
of the immunoblot signals obtained with the antibody Ab-Col15-2 showed
that the stability of rCol15 was reduced by omission of ascorbate or by
substitution of the Gly residue at position 627. Panel A,
rCol15 produced in the presence of 50 µg/ml ascorbic acid lost its
stability to about 50% at 25 °C. Panel B, rCol15
produced without ascorbic acid lost its stability to about 50% at
18 °C. Panel C, rCol15-G627V was produced by converting
the codon for glycine at amino acid position 627 to a codon for valine.
Compared with the 34-kDa undigested sample (U), trypsin
treatment already at the lowest temperature, 4 °C, resulted in an
appearance of intermediate digestion product of 26 kDa. The 34-kDa
rCol15-G627V band disappeared at 16 °C, and the 26-kDa intermediate
fragment was lost to about 50% at 21 °C.
1 family mediated cellular interactions with
rCol15 (Fig. 5).

View larger version (39K):
[in a new window]
Fig. 4.
Cell adhesion to rCol15. A,
freshly suspended L132 fibroblasts (left panel) or HaCaT
cells (right panel) were seeded on wells coated with
different concentrations of native or heat-denatured rCol15. The extent
of cell adhesion was determined by a colorimetric assay (31).
B, the maximal adhesion to native or heat-denatured rCol15
recorded in the dose-response curves shown in panel A were
compared with that observed on collagen IV. The histograms show
adhesion of Wi26, A431, L132, and HaCaT cells. C, morphology
of L132 fibroblasts (panels a-c) and HaCaT epithelial cells
(panels d-f) attached to collagen IV (panels a
and d), native rCol15 (panels b and
e), and to denatured rCol15 (panels c and
f). Photographs were taken at the end of the 45-min adhesion
period, after washing off unattached cells. Attached cells were fixed
and stained as described (31).

View larger version (19K):
[in a new window]
Fig. 5.
Inhibition of cell adhesion to rCol15 by
a
1 integrin antibody. Cells were seeded
on substrate-coated wells in the presence or absence of a monoclonal
antibody to
1 integrin (P4C10) diluted 1:500 or 1:2,000 as
indicated. The extent of cell adhesion was measured after 45 min by a
colorimetric assay (31).

View larger version (90K):
[in a new window]
Fig. 6.
IgG and IgA autoantibodies in bullous skin
diseases target rCol15. Panel A, immunoblotting of
rCol15 with patient autoimmune sera. As a positive control, the
antibody Ab-Col15-2 was used (lane C). rCol15 was recognized
by IgG autoantibodies from a pemphigoid serum (lane 1) and
by IgA autoantibodies from a linear IgA dermatosis serum (lane
2). Panel B, autoantibodies from a pemphigoid serum
immunoadsorbed with rCol15 were used for indirect immunofluorescence
staining of normal human skin. The affinity-purified IgG to rCol15
stained the dermo-epidermal basement membrane zone in a linear fashion
(arrow).
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
1 integrin-dependent manner. The native
triple-helical rod of fibrillar collagens I, II, III, and V, basement
membrane collagen IV, and of microfibrillar collagen VI, has been found to induce cell adhesion (for review, see Ref. 41), and this may
represent a general property of collagenous helices. Even though many
collagens upon denaturation show diminished cell adhesion activity
(42-45), heat-denatured rCol15 bound cells efficiently. In some
similar cases, cell adhesion to denatured collagens involves RGD motifs
in the primary sequence of the
chains which become exposed upon
unfolding of the triple-helices (46, 47). Instead of an RGD, rCol15
contains a GER sequence that is recognized by integrins in collagen I
(48). Induction of cell adhesion by denatured rCol15 is also
interesting in the context of shedding of the ectodomain, which may
generate new cell binding sites. However, the exact nature of the cell
adhesion and integrin binding sites in rCol15 remains to be determined.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
1.
Prockop, D.,
and Kivirikko, K. I.
(1995)
Annu. Rev. Biochem.
64,
403-434[CrossRef][Medline]
[Order article via Infotrieve]
2.
Pihlajaniemi, T.,
and Rehn, M.
(1995)
Prog. Nucleic Acids Res. Mol. Biol.
50,
225-262[Medline]
[Order article via Infotrieve]
3.
Jones, J. C. R.,
Hopkinson, S.,
and Goldfinger, L. E.
(1998)
Bioessays
20,
488-494[CrossRef][Medline]
[Order article via Infotrieve]
4.
Borradori, L.,
and Sonnenberg, A.
(1999)
J. Invest. Dermatol.
112,
411-418[CrossRef][Medline]
[Order article via Infotrieve]
5.
Giudice, G. J.,
Emery, D. J.,
and Diaz, L. A.
(1992)
J. Invest. Dermatol.
99,
243-250[CrossRef][Medline]
[Order article via Infotrieve]
6.
Schäcke, H.,
Schumann, H.,
Hammami-Hauasli, N.,
Raghunath, M.,
and Bruckner-Tuderman, L.
(1998)
J. Biol. Chem.
273,
25937-25943 7.
Hirako, Y.,
Usukura, J.,
Uematsu, J.,
Hashimoto, T.,
Kitajima, Y.,
and Owaribe, K.
(1998)
J. Biol. Chem.
273,
9711-9717 8.
Balding, S. H.,
Diaz, L. A.,
and Giudice, G. J.
(1997)
Biochemistry
36,
8821-8830[CrossRef][Medline]
[Order article via Infotrieve]
9.
Hirako, Y.,
Usukura, J.,
Nishizawa, Y.,
and Owaribe, K.
(1996)
J. Biol. Chem.
271,
13739-13745 10.
Borradori, L.,
Koch, P. J.,
Niessen, C. M.,
Erkeland, S.,
van Leusden, M. R.,
and Sonnenberg, A. J.
(1997)
J. Cell Biol.
136,
1333-1347 11.
Borradori, L.,
Chavanas, S.,
Schaapveld, R. Q. J.,
Gahnoux-Palacios, L.,
Calfat, J.,
Meneguzzi, G.,
and Sonnenberg, A. J.
(1998)
Exp. Cell Res.
239,
463-476[CrossRef][Medline]
[Order article via Infotrieve]
12.
Aho, S.,
and Uitto, J.
(1998)
Biochem. Biophys. Res. Commun.
243,
694-699[CrossRef][Medline]
[Order article via Infotrieve]
13.
Schaapveld, R. Q. J.,
Borradori, L.,
Geerts, D.,
Van Leusden, M. R.,
Kuikman, I.,
Nievers, M. G.,
Niessen, C. M.,
Steenbergen, R. D. M.,
Snijders, P. J. F.,
and Sonnenberg, A.
(1998)
J. Cell Biol.
142,
271-284 14.
Hopkinson, S. B.,
Findlay, K.,
deHart, G. W.,
and Jones, J. C. R.
(1998)
J. Invest. Dermatol.
111,
1015-1022[CrossRef][Medline]
[Order article via Infotrieve]
15.
McGrath, J. A.,
Gatalica, B.,
Christiano, A. M.,
Li, K.,
Owaribe, K.,
McGillan, J. R.,
Eady, R. A. J.,
and Uitto, J.
(1995)
Nat. Genet.
11,
83-86[CrossRef][Medline]
[Order article via Infotrieve]
16.
McGrath, J. A.,
Gatalica, B.,
Li, K.,
Dunnill, M. G.,
McGillan, J. R.,
Christiano, A. M.,
Eady, R. A. J.,
and Uitto, J.
(1996)
Am. J. Pathol.
148,
1787-1796[Abstract]
17.
Gatalica, B.,
Pulkkinen, L.,
Li, K.,
Kuokkanen, K.,
Ryynänen, M.,
McGrath, J.,
and Uitto, J.
(1997)
Am. J. Hum. Genet.
60,
352-365[Medline]
[Order article via Infotrieve]
18.
Schumann, H.,
Hammami-Hauasli, N.,
Pulkkinen, L.,
Mauviel, A.,
Küster, W.,
Lüthi, U.,
Owaribe, K.,
Uitto, J.,
and Bruckner-Tuderman, L.
(1997)
Am. J. Hum. Genet.
60,
1344-1353[Medline]
[Order article via Infotrieve]
19.
Floeth, M.,
Fiedorowicz, J.,
Schäcke, H.,
Hammami-Hauasli, N.,
Owaribe, L.,
Trüeb, R. M.,
and Bruckner-Tuderman, L.
(1998)
J. Invest. Dermatol.
111,
528-533[CrossRef][Medline]
[Order article via Infotrieve]
20.
Pulkkinen, L.,
and Uitto, J.
(1998)
Exp. Dermatol.
7,
46-64[Medline]
[Order article via Infotrieve]
21.
Bruckner-Tuderman, L.
(2000)
in
Connective Tissue and Its Heritable Disorders: Molecular, Genetic and Medical Aspects
(Royce, P.
, and Steinmann, B., eds)
, John Wiley and Sons, New York, in press
22.
Stanley, J.
(1995)
J. Exp. Med.
181,
1-4 23.
Balding, S. D.,
Prost, C.,
Diaz, L. A.,
Bernard, P.,
Bedane, C.,
Aberdam, D.,
and Giudice, G. J. J.
(1996)
J. Invest. Dermatol.
106,
141-146[CrossRef][Medline]
[Order article via Infotrieve]
24.
Ghohestani, R. F.,
Nicolas, J. F.,
Kanitakis, J.,
and Claudy, A.
(1997)
J. Invest. Dermatol.
108,
854-858[CrossRef][Medline]
[Order article via Infotrieve]
25.
Zillikens, D.,
Pose, P. A.,
Balding, S. D.,
Liu, Z.,
Olague-Marchan, M.,
Diaz, L. A.,
and Giudice, G. J.
(1997)
J. Invest. Dermatol.
109,
573-579[CrossRef][Medline]
[Order article via Infotrieve]
26.
Haase, C.,
Büdinger, L.,
Borradori, L.,
Yee, C.,
Merk, H. F.,
Yancey, K.,
and Hertl, M.
(1998)
J. Invest. Dermatol.
110,
282-286[CrossRef][Medline]
[Order article via Infotrieve]
27.
Zone, J. J.,
Taylor, T. B.,
Meyer, L. J.,
and Petersen, M. J
(1998)
J. Invest. Dermatol.
110,
207-210[CrossRef][Medline]
[Order article via Infotrieve]
28.
Perriard, J.,
Jaunin, F.,
Favre, B.,
Büdinger, L.,
Hertl, M.,
Saurat, J.-H.,
and Borradori, L.
(1999)
J. Invest. Dermatol.
112,
141-147[CrossRef][Medline]
[Order article via Infotrieve]
29.
Kohfeldt, E.,
Maurer, P.,
Vannahme, C.,
and Timpl, R.
(1997)
FEBS Lett.
414,
557-561[CrossRef][Medline]
[Order article via Infotrieve]
30.
Bruckner, P.,
and Prockop, D. J.
(1981)
Anal. Biochem.
110,
360-368[CrossRef][Medline]
[Order article via Infotrieve]
31.
Rousselle, P.,
and Aumailley, M.
(1994)
J. Cell Biol.
125,
205-214 32.
Schumann, H., Baetge, J., Tasanen, K., Wojnarowska, F., Schäcke,
H., Zillikens, D., and Bruckner-Tuderman, L. (2000)
Am. J. Pathol., in press
33.
Bruckner-Tuderman, L.,
Nilssen, Ö.,
Zimmermann, D.,
Dours-Zimmermann, M.-T.,
Kalinke, U. D.,
Gedde-Dahl, T., Jr.,
and Winberg, J.-O.
(1995)
J. Cell Biol.
131,
551-559 34.
Gammon, W. R.,
Fine, J.-D.,
Forbes, M.,
and Briggman, R. A.
(1992)
J. Am. Acad. Dermatol.
27,
79-87[Medline]
[Order article via Infotrieve]
35.
Kivirikko, K. I.,
Myllylä, R.,
and Pihlajaniemi, T.
(1992)
in
Post-translational Modifications of Proteins
(Harding, J. J.
, and Crabbe, M. J. C., eds)
, pp. 1-51, CRC Press, Boca Raton, FL
36.
Piez, K. A.,
and Sherman, M. R.
(1970)
Biochemistry
9,
4129-4133[CrossRef][Medline]
[Order article via Infotrieve]
37.
Pas, H. H.,
Kloosterhuis, G. J.,
Heeres, K.,
van der Meer, J. B.,
and Jonkman, M. F.
(1997)
J. Invest. Dermatol.
108,
423-429[CrossRef][Medline]
[Order article via Infotrieve]
38.
Zafarullah, K.,
Sieron, A. L.,
Fertala, A.,
Tromp, G.,
Kuivaniemi, H.,
and Prockop, D. J.
(1997)
Matrix Biol.
16,
245-253[CrossRef][Medline]
[Order article via Infotrieve]
39.
Arnold, W. V.,
Fertala, A.,
Sieron, A. L.,
Hattori, H.,
Mechling, D.,
Bächinger, H.-P.,
and Prockop, D. J.
(1998)
J. Biol. Chem.
273,
31822-31828 40.
Hammami-Hauasli, N.,
Schumann, H.,
Raghunath, M.,
Kilgus, O.,
Luethi, U.,
Luger, T.,
and Bruckner-Tuderman, L.
(1998)
J. Biol. Chem.
273,
19228-19234 41.
Aumailley, M.,
and Gayraud, B.
(1998)
J. Mol. Med.
76,
253-265[CrossRef][Medline]
[Order article via Infotrieve]
42.
Aumailley, M.,
Mann, K.,
von der Mark, H.,
and Timpl, R.
(1989)
Exp. Cell Res.
181,
463-474[CrossRef][Medline]
[Order article via Infotrieve]
43.
Gullberg, D.,
Gehlsen, K. R.,
Turner, D. C.,
Ahlen, K.,
Zijenah, L. S.,
Barnes, M. J.,
and Rubin, K.
(1992)
EMBO J.
11,
3865-3873[Medline]
[Order article via Infotrieve]
44.
Ruggiero, F.,
Champliaud, M. F.,
Garrone, R.,
and Aumailley, M.
(1994)
Exp. Cell Res.
210,
215-223[CrossRef][Medline]
[Order article via Infotrieve]
45.
Tuckwell, D. S.,
Ayad, S.,
Grant, M. E.,
Takigawa, M.,
and Humphries, M. J.
(1994)
J. Cell Sci.
107,
993-1005[Abstract]
46.
Davis, G. E.
(1992)
Biochem. Biophys. Res. Commun.
182,
1025-1031[CrossRef][Medline]
[Order article via Infotrieve]
47.
Pfaff, M.,
Aumailley, M.,
Specks, U.,
Knolle, J.,
Zerwes, H. G.,
and Timpl, R.
(1993)
Exp. Cell Res.
206,
167-176[CrossRef][Medline]
[Order article via Infotrieve]
48.
Knight, C. G.,
Morton, L. F.,
Onley, D. J.,
Peachey, A. R.,
Messent, A. J.,
Smethurst, P. A.,
Tuckwell, D. S.,
Farndale, R. W.,
and Barnes, M. J.
(1998)
J. Biol. Chem.
273,
33287-33294 49.
Giudice, G. J.,
Emery, D. J.,
Zelickson, B. D.,
Anhalt, G. J.,
Liu, Z.,
and Diaz, L. A.
(1993)
J. Immunol.
151,
5742-5750[Abstract]
50.
Nakatani, C.,
Muramatsu, T.,
and Shirai, T.
(1998)
Br. J. Dermatol.
139,
365-370[CrossRef][Medline]
[Order article via Infotrieve]
51.
Nie, Z.,
and Hashimoto, T.
(1999)
J. Invest. Dermatol.
112,
254-255[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. Herz, M. Aumailley, C. Schulte, U. Schlotzer-Schrehardt, L. Bruckner-Tuderman, and C. Has Kindlin-1 Is a Phosphoprotein Involved in Regulation of Polarity, Proliferation, and Motility of Epidermal Keratinocytes J. Biol. Chem., November 24, 2006; 281(47): 36082 - 36090. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-W. Franzke, C. Has, C. Schulte, L. Huilaja, K. Tasanen, M. Aumailley, and L. Bruckner-Tuderman C-terminal Truncation Impairs Glycosylation of Transmembrane Collagen XVII and Leads to Intracellular Accumulation J. Biol. Chem., October 6, 2006; 281(40): 30260 - 30268. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-W. Franzke, P. Bruckner, and L. Bruckner-Tuderman Collagenous Transmembrane Proteins: Recent Insights into Biology and Pathology J. Biol. Chem., February 11, 2005; 280(6): 4005 - 4008. [Full Text] [PDF] |
||||
![]() |
C.-W. Franzke, K. Tasanen, L. Borradori, V. Huotari, and L. Bruckner-Tuderman Shedding of Collagen XVII/BP180: STRUCTURAL MOTIFS INFLUENCE CLEAVAGE FROM CELL SURFACE J. Biol. Chem., June 4, 2004; 279(23): 24521 - 24529. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tasanen, L. Tunggal, G. Chometon, L. Bruckner-Tuderman, and M. Aumailley Keratinocytes from Patients Lacking Collagen XVII Display a Migratory Phenotype Am. J. Pathol., June 1, 2004; 164(6): 2027 - 2038. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Mayer, G. Boileau, and M. Bendayan Sorting of Furin in Polarized Epithelial and Endothelial Cells: Expression Beyond the Golgi Apparatus J. Histochem. Cytochem., May 1, 2004; 52(5): 567 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Waki, T. Yamauchi, J. Kamon, Y. Ito, S. Uchida, S. Kita, K. Hara, Y. Hada, F. Vasseur, P. Froguel, et al. Impaired Multimerization of Human Adiponectin Mutants Associated with Diabetes: MOLECULAR STRUCTURE AND MULTIMER FORMATION OF ADIPONECTIN J. Biol. Chem., October 10, 2003; 278(41): 40352 - 40363. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Parikka, T. Kainulainen, K. Tasanen, A. Vaananen, L. Bruckner-Tuderman, and T. Salo Alterations of Collagen XVII Expression During Transformation of Oral Epithelium to Dysplasia and Carcinoma J. Histochem. Cytochem., July 1, 2003; 51(7): 921 - 929. [Abstract] |